The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer.
Kassem S FarajSamuel R KaufmanLindsey A HerrelAvinash MagantyMary OerlineMegan E V CaramVahakn B ShahinianBrent K HollenbeckPublished in: Cancer medicine (2023)
In the year following acquisition of urology practices, private equity did not increase prostate cancer spending, the use of treatment or diagnostic testing in men with prostate cancer. Future work should evaluate the effects of private equity acquisition on practice patterns and quality over a longer time horizon.